Cargando…
In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study
BACKGROUND: Ibrexafungerp (SCY-078) is the newest oral and intravenous antifungal drug with broad activity, currently undergoing clinical trials for invasive candidiasis. OBJECTIVE: The aim of this study was to assess the in vitro activity of ibrexafungerp and comparators against a collection of 434...
Autores principales: | Quindós, Guillermo, Miranda-Cadena, Katherine, San-Millán, Rosario, Borroto-Esoda, Katyna, Cantón, Emilia, Linares-Sicilia, María José, Hamprecht, Axel, Montesinos, Isabel, Tortorano, Anna Maria, Prigitano, Anna, Vidal-García, Matxalen, Marcos-Arias, Cristina, Guridi, Andrea, Sanchez-Reus, Ferran, Machuca-Bárcena, Jesús, Rodríguez-Iglesias, Manuel Antonio, Martín-Mazuelos, Estrella, Castro-Méndez, Carmen, López-Soria, Leyre, Ruiz-Gaitán, Alba, Fernandez-Rivero, Marcelo, Lorenzo, Damaris, Capilla, Javier, Rezusta, Antonio, Pemán, Javier, Guarro, Josep, Pereira, Joana, Pais, Célia, Romeo, Orazio, Ezpeleta, Guillermo, Jauregizar, Nerea, Angulo, David, Eraso, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149255/ https://www.ncbi.nlm.nih.gov/pubmed/35651755 http://dx.doi.org/10.3389/fcimb.2022.906563 |
Ejemplares similares
-
672. Activity of Ibrexafungerp (Formerly SCY-078) Against Candida auris: In vitro, In Vivo, and Clinical Case Studies of Candidemia
por: Barat, Stephen, et al.
Publicado: (2019) -
1251. Prevention of Pneumocystis Pneumonia by Ibrexafungerp in a Murine Prophylaxis Model
por: Borroto-Esoda, Katyna, et al.
Publicado: (2020) -
SCY-078 Demonstrates Significant Tissue Penetration in Rats and Mice Following Oral or IV Administration
por: Barat, Stephen, et al.
Publicado: (2017) -
733. Ibrexafungerp Demonstrates Potent and Consistent In Vitro Activity Against >400 Global Candida auris Isolates, Including isolates with Elevated MIC’s to Echinocandins
por: Borroto-Esoda, Katyna, et al.
Publicado: (2020) -
In Vitro pH Activity of Ibrexafungerp against Fluconazole-Susceptible and -Resistant Candida Isolates from Women with Vulvovaginal Candidiasis
por: Sobel, Jack D., et al.
Publicado: (2021)